Literature DB >> 36237453

CT Follow-Up of Postoperative Bronchopleural Fistula: Risk Factors for Progression to Chronic Complicated Infection.

Ji-Yeon Han, Ki-Nam Lee, Yoo Sang Yoon, Jihyun Lee, Hongyeul Lee, Seok Jin Choi, Hye Jung Choo, Jin Wook Baek, Young Jin Heo, Gi Won Shin, Jinyoung Park, Dasom Kim.   

Abstract

Purpose: We evaluated the risk factors for progression to chronic complicated bronchopleural fistula (BPF) after pulmonary resection using follow-up CT. Materials and
Methods: We retrospectively reviewed 45 cases with BPF that had undergone pulmonary resection during 2010-2018. We compared the clinical and radiological characteristics of those with complicated BPF (n = 24) and those without complicated (sterilized) BPF (n = 21). The clinical and radiological risk factors for progression to chronic complicated BPF were examined by logistic regression analysis.
Results: The thickness of the pleural cavity wall (p = 0.022), the size of the pleural cavity (p = 0.029), and the size increase of BPF on follow-up (p = 0.012) were significantly different between the two groups. The risk factors for progression to chronic complicated BPF were age > 70 years (odds ratio, 6.43; 95% confidence interval, 1.2-33.7), the thickness of the cavity wall > 5 mm (odds ratio, 52.5; 95% confidence interval, 5.1-545.4), and an increase in the size of the pleural cavity on follow-up CT (odds ratio, 12.5; 95% confidence interval, 2.1-73.5), only in the univariate analysis.
Conclusion: The risk factors for progression to chronic complicated BPF can be evaluated using follow-up CT. Copyrights
© 2021 The Korean Society of Radiology.

Entities:  

Keywords:  Fistula; Lobectomy; Pneumonectomy

Year:  2020        PMID: 36237453      PMCID: PMC9432413          DOI: 10.3348/jksr.2020.0013

Source DB:  PubMed          Journal:  Taehan Yongsang Uihakhoe Chi        ISSN: 1738-2637


INTRODUCTION

Although the incidence of bronchopleural fistula (BPF) after pulmonary resection has decreased to 1–2% in recent years, when it occurs, management and treatment remain a major challenge (1). The aim of management in this condition is to control active infection in the pleural cavity with closure of the fistula; however, there is still a considerable failure rate (23). The incidence of initial treatment failure and progression to a refractory fistula with chronic empyema is known to be 8.3–25% (45). Empyema-complicated BPF is particularly difficult to manage, despite various treatment options, including surgical and bronchoscopic maneuvers, has a long recovery period (6). Early prediction of refractory fistula with chronic infection might reflect the response to current treatment and might facilitate deciding on changes in the treatment plan, which might reduce the overall duration and cost of treatment. The risk factors for developing BPF have been widely studied; however, limited data are available on the prediction of progression to chronic disease. The purpose of this study was to identify factors that associated with the progression to chronic complicated BPF after pulmonary resection, based on CT follow-up.

MATERIALS AND METHODS

STUDY POPULATION

This retrospective study was approved by the Institutional Review Board of both participating hospitals (D-1810-017-002, 19-0164) and the need to obtain informed patient consent was waived. We retrospectively identified 184 patients with “bronchopleural fistula” on radiology reports in the radiology information system databases of two hospitals, between July 2010 and June 2018. Patients with BPF caused by pulmonary infection (n = 33), tuberculosis (n = 92), tumor (n = 4), and uncertain imaging findings for the diagnosis of BPF (n = 6) were excluded. In addition, patients who had no follow-up CT (n = 4) were also excluded. Forty-five patients who had developed BPF after pulmonary resection were finally included (Fig. 1).
Fig. 1

Patient selection and the number of patients showing progression to chronic complicated postoperative BPF.

BPF = bronchopleural fistula

CT TECHNIQUES

CT scans were obtained with Brilliance iCT (Philips Medical Systems, Cleveland, OH, USA), Somatom Definition AS (Siemens Healthcare, Erlangen, Germany), Somatom Drive (Siemens Healthcare), Somatom Perspective (Siemens Healthcare), or Discovery CT 750HD (GE Healthcare, Waukesha, WI, USA). The CT parameters were as follows: 0.9 or 0.625 mm collimation; 2–5 mm thickness and 2–5 mm increment without gap, and 1-mm thickness with 5-mm gap; high spatial-frequency algorithm; 120 kVp, and 100 effective mAs, with dose modulation for chest CT with enhancement. Coronal multiplanar reformation images with a section thickness of 3 mm and an increment of 3 mm were routinely constructed.

CT ANALYSIS

All CT images were interpreted by two radiologists in consensus. An imaging diagnosis of BPF was made when the presence of a definite fistulous tract was detected between the pleural space and airway (direct), or a suspicious air bubble, or a suspicious but not definite communication between the pleural space and airway (indirect) was noted (7). Location of the BPF (central, more proximal than the lobar bronchus or peripheral, more distal than the lobar bronchus), onset of BPF (duration from operation to development of BPF), stump length, the size of the pleural cavity, and the thickness of the pleural cavity wall were evaluated on initial CT images when a BPF was diagnosed, or at the first follow-up CT when a complicated BPF developed. The thickness of the cavitary wall was measured at the thickest portion of the pleura in nondependent side and the size of the cavity was measured by the longest length of the aerated pleura either in axial or coronal scan (Fig. 2). Stump length was measured only in cases of central BPF. Measurements of continuous variables (stump length, size of pleural cavity, and thickness of pleural cavity wall) by each observer were averaged for statistical analysis. After the initial CT evaluation, all follow-up CTs were reviewed by 2 observers in consensus. Duration of BPF was defined by the period from the time of the first CT scan when BPF was detected until the time of the last follow-up CT, or the time when BPF was no longer visible. Development of complicated BPF was defined as the presence of empyema (air-fluid level with pleural thickening), recurrent aspiration pneumonia, and postoperative acute lung injury during the follow-up. We defined chronic infection when the complicated BPF persisted over 1 year from the development of the infection. The change in size of the aerated pleural cavity (increased size of pleural cavity/partially decreased size/total resolution of pleural cavity) and total duration of BPF were evaluated at follow-up CT.
Fig. 2

Measurement of the CT parameters of BPF in patients who had undergone a right upper lobectomy for lung cancer.

A. A central direct BPF distal to a long stump (arrow) is detected 4 months after the operation. The type, location, and stump length are evaluated on the initial CT.

B. After 9 months, a complicated BPF in the form of empyema is first detected. The thickness of the cavitary wall at the non-dependent portion of the pleura (black arrow) and the size of the cavity (white dotted arrow) are measured. The size of the aerated pleural cavity is decreased compared with the cavity shown in (A).

BPF = bronchopleural fistula

CLINICAL ANALYSIS

Bronchosocpy was performed in 16 cases, and a direct fistulous tract was found in five cases. The presence of thoracic infection was confirmed either by positive microbial staining and/or culture of sputum, blood, pleural, bronchoscopic lavage, or by serum aspergillus antigen test. The patients with BPF who did not show evidence of thoracic infection in clinical and radiologic analysis were considered to have a sterilized pleural cavity. Three patients with complicated BPF were lost during the follow-up, before 1 year. Patients expired due to postoperative acute lung injury (n = 2), pneumonia (n = 2), or recurrence of cancer (n = 5) during the follow-up period. The median duration of radiographic follow-up was 10 months (range, 0.6–73 months).

STATISTICAL ANALYSIS

Patients with and without total resolution were compared by Student's t test or the Mann–Whitney U and chi-square tests. Clinical and radiological characteristics were compared between the group who had complicated BPF and the group who had sterilized BPF, using either Student's t test or the Mann–Whitney U and chi-square tests. Logistic regression analysis was performed to identify the risk factors for progression to chronic complicated BPF. Variables used in the univariate analysis included clinical factors (age, sex, cause or extent of the operation, onset of BPF, postoperative chemoradiation therapy) and CT findings (type and location of BPF, stump length, size of the pleural cavity, thickness of the pleural cavity wall, and course of BPF). Significant variables in the univariate analysis were further analyzed in a multivariate logistic regression analysis. Statistical analysis was performed using SPSS version 25.0 (IBM Corp., Armonk, NY, USA). p values less than 0.05 were considered significant.

RESULTS

Among the 184 patients with BPF, 26.6% (n = 49) of cases were related to pulmonary resection. The causes of pulmonary resection were lung cancer (n = 26), metastasis (n = 11), aspergilloma (n = 5), tuberculosis (n = 4) and other benign disease (n = 3). Patient selection and the number of those who progressed to chronic complications in postoperative BPF are summarized in Fig. 1. In CT analysis, postoperative BPF was common in right side (32/45, 71.1%), and in upper lobe (24/45, 53.3%). Direct type was more common in peripheral BPF (15/22, 68.2%), than in central BPF (9/23, 39.1%). In follow up CT scans, 30.4% (7/23) of cases showed size increase in central BPF, while 13.6% (3/22) of cases showed size increase in peripheral BPF. In clinical analysis of postoperative BPF, 46.7% (21/45) of cases did not have a thoracic infection, and were considered to have a sterilized pleural cavity. None of the patients showed meaningful evidence of infection in laboratory findings. Complicated BPF had developed in 53.3% (24/45) patients in the form of empyema (79.2%, n = 19), recurrent aspiration pneumonia (41.7%, n = 10), fungal infection (12.5%, n = 3), and postoperative lung injury (12.5%, n = 3). BPF-associated deaths were caused by pneumonia (n = 3) and postoperative lung injury (n = 1), and the mortality rate of postoperative BPF was 8.9% (4/45). Among the cases of complicated BPF (n = 24), 3 patients were lost to follow-up before reaching 1 year of thoracic infection, while 8 patients had progressed to chronic infection (33.3%, 8/24). Clinical information of cases with chronic complicated BPF is reported in Table 1. Surgical management was required in 42.9% (3/7) of patients with chronic complicated BPF. In one patient, surgery failed to manage the chronic infection, and one patient died of pneumonia during the follow-up.
Table 1

Cases of Chronic Complicated Bronchopleural Fistula*

CaseSex/AgeCause of OperationExtent of OperationDuration (Months)Form of Chronic InfectionLaboratory Finding or CultureManagementClinical Outcome
1M/62Lung cancerLobectomy73Chronic pulmonary aspergillosis, empyemaAspergillus antigenAntibioticsImproved
2M/63Fungal ballLobectomy28Chronic pulmonary aspergillosis, empyemaAspergillus antigenSurgeryImproved
3M/66Lung cancerLobectomy29Aspiration pneumonia, empyemaKlebsiella pneumoniae AntibioticsPersistent
4M/70Lung cancerLobectomy12Aspiration pneumonia, empyemaEscherichia coli AntibioticsDeath (pneumonia)
5M/73Lung cancerLobectomy24Aspiration pneumonia, empyemaAcinetobacter baumannii AntibioticsPersistent
6M/70Fungal ballLobectomy55EmpyemaBacillus species SurgeryPersistent
7M/78Lung cancerLobectomy16Aspiration pneumonia, empyemaKlebsiella pneumoniae AntibioticsDeath (cancer)
8M/76BullaeWedge19Fungal ball, empyemaStreptococcus anginosus SurgeryImproved

*Cases of complicated bronchopleural fistula to progress chronic infection.

Approximately 44.4% (20/45) of patients showed total resolution of pleural cavity on longitudinal follow-up CT. These patients were significantly different from patients who did not, in terms of development of complicated BPF (p = 0.038), total duration of BPF (mean 9.5 months vs. 18.7 months, p = 0.039) and the thickness of the cavity wall (mean 3.3 mm vs. 4.4 mm, p = 0.044). Sex, cause of operation, peripheral BPF, indirect BPF, extent of operation, and a history of chemoradiation therapy did not increase the frequency of total resolution. Patient characteristics and CT analysis of the groups with complicated BPF and sterilized BPF are reported in Table 2. Any of clinical factors were not significantly different between the two groups. In sterilized BPF group, the size of pleural cavity was smaller (p = 0.029), and the resolution of pleural cavity was common on follow-up CT (p = 0.014), compared with the complicated BPF group. The thickness of pleural cavity was also thinner in sterilized BPF with near statistical significance (p = 0.063).
Table 2

Comparison of the Patient Characteristics with and without Complicated BPF

Sterilized BPF (n = 21)Complicated BPF (n = 24)p-Value
Age60.963.50.392
Sex (M/F)18/425/20.252
Diabetes mellitus540.713
Cause of operation0.354
Malignant1819
Benign48
Extent of pulmonary resection0.498
Pneumonectomy31
Bilobectomy13
Lobectomy1217
Segmentectomy or wedge resection66
Postoperative management
Radiation therapy280.152
Chemotherapy770.650
Onset of BPF (months)4.0 (0.5–300.0)3.0 (0.2–121.0)0.647*
Total duration of BPF (months)8.0 (0.6–48.0)13.0 (1.0-73.0)0.214*
Management of BPF
Surgery140.362
Chest tube insertion390.182
CT findings
Direct/indirect9/1315/120.308
Central/peripheral10/1215/120.482
Stump length (mm)11.76.10.193
Recurrence270.159
Size of cavity (mm)62.786.80.026
Thickness of pleural cavity wall (mm)3.0 (1.0–5.0)4.0 (1.0–9.0)0.063*
Size change of cavity on follow-up CT0.014
Increase in size of cavity190.012
Partial decrease in size of cavity781.0
Total resolution of cavity1370.038

*Mann-Whitney U test. Relevant data are medians with ranges in parentheses.

BPF = bronchopleural fistula

In logistic regression analysis, factors related to progression to chronic complicated BPF were age > 70 years (p = 0.028), thickness of the pleural cavity wall > 5 mm (p = 0.001), and increase in the size of the cavity on follow-up (p = 0.005) (Table 3). However, 95% confidence interval of the thickness of cavity wall was wide. Multivariate analysis failed to demonstrate a significant association of any of the factors above with progression to chronic complicated BPF. A representative case of progression to chronic complicated BPF is shown in Fig. 3.
Table 3

Risk Factors of Chronic Complicated BPF in the Logistic Regression Analysis

Risk Factorβp-ValueOR95% CI
Old age (≥ 70)1.8610.0286.431.2–33.7
Benign cause of operation1.030.232.800.5–15.0
Pulmonary resection
Pneumonectomy0
Bilobectomy0
Lobectomy1.8280.1046.220.7–56.2
Postoperative chemoradiation0.0310.9690.9690.2–4.8
Direct BPF0.2740.7340.760.2–3.7
Central BPF0.7470.3552.10.4–10.3
Thickness of pleural cavity wall (≥ 5 mm)3.5830.00152.55.1–545.4
Recurred primary disease0.9160.3472.50.4–16.9
Increase in size of cavity on follow-up CT2.5260.00512.52.1–73.5

BPF = bronchopleural fistula, CI = confidence interval, OR = odds ratio

Fig. 3

63-year old male with chronic complicated BPF after a right upper lobectomy for aspergillosis.

A. Aerated pleural cavity and air bubbles beneath the surgical clip (arrow), suggesting an indirect BPF. These are first detected in the right upper thorax on a non-contrast coronal CT scan performed 30 months after the operation.

B. Serial contrast-enhanced CT 10 months after the operation shows that the size of the pleural cavity had increased.

C. After another 7 months, an axial lung window scan demonstrates an air-fluid level and irregular internal debris inside the cavity with the development of consolidation around the cavity (arrows). Bronchoscopic washing demonstrates an elevated titer of aspergillus antigen (3.71). Conservative management failed, and surgery was required.

BPF = bronchopleural fistula

DISCUSSION

Although a wide variety of bronchoscopic and surgical maneuvers have been developed, no gold-standard management for BPF has been established to date (8). Some recent studies have attributed importance to conservative management of BPF by infection control, using imaging follow-up or endoscopic applications, to avoid invasive surgical techniques (891011). As conservative treatment requires a long period of time, determination of treatment failure and the time point at which the treatment option should be changed to avoid reaching refractory empyema is of importance during the conservative management follow-up period. The risk factors for development of postoperative BPF, including clinical factors and operative method, have been widely studied (612131415). However, prognostic factors related to progression of BPF are not well known. To our knowledge, no previous studies have assessed the risk factors associated with refractory complicated BPF. Number of central (n = 23) and peripheral (n = 22) BPF were similar in postoperative BPF in our study. Postlobectomy or pneumonectomy BPF are suspected by clinical signs and symptoms by thoracic surgeons initially (15). As clinical outcome of peripheral fistulas are known to be favorable even with conservative treatment (13), subclinical or peripheral BPF can be easily neglected by thoracic surgeons. We had selected the patients by CT image, which lead to increase the number of subclinical or sterilized BPF that thoracic surgeons could not have noticed. Radiologic features that are suggestive of the presence of a BPF are usually indirect (16), however direct type were more common in peripheral BPF in our study, similar with past study (7). Our study demonstrated that postoperative BPF does not always result in thoracic infection. In our study, 46.7% (21/45) of postoperative BPF cases did not have a thoracic infection, and 59.1% (13/21) of sterilized BPF showed total resolution on follow-up CT. When thoracic infection was present, 33.3% (8/24) of patients with complicated BPF progressed to chronic infection in longitudinal follow-up of postoperative BPF. The incidence of progression to chronic complicated BPF was 17.8% (8/45) among postoperative BPF cases in this study. In a study about the natural course of post-pneumonectomy BPF, Hollaus et al. (4) reported that 16.7% (16/96) patients were discharged with chronic empyema, with permanent drainage. Westcott and Volpe (5) reported that 20% (5/20) of nonoperative BPF progressed to chronic disease, as visualized in thin-section CT. However, the incidence of chronic disease after pulmonary resection had not been reported in previous studies. As slow progression of disease may not be apparent in clinical findings, CT analysis might be necessary in the follow-up of BPF. Surgery was required in 37.5% (3/8) of patients with chronic complicated BPF in this study. Fistula repair is not necessarily the first step in managing empyema-complicated BPF (10). Many studies have described the safety of conservative management of BPF and minimizing surgery (91017). In our three patients who underwent surgical correction, all cases received delayed medical treatment because of loss to follow-up and failure to notice the complications. Delayed diagnosis and treatment contribute to multiple operations and morbidity. Late-developing fistulas are particularly difficult to manage, because of the delayed diagnosis (1). We emphasize the necessity of CT follow-up both in conservative and surgical management, particularly in cases of delayed BPF, to confirm diminution of the pleural cavity during treatment and to determine the appropriate time for surgical correction. Patients who showed total resolution were younger, had fewer complications, and thinner cavitary walls than the patients who did not show resolution. The presence of complications at postoperative BPF might be important factors for patients' prognosis. Mortality related to BPF is related to the degree of contamination of the pleural space (1). In a sterilized cavity, formation of granuloma and scars may minimize the cavity and the fistula may gradually be occluded (10). Prevention of development of thoracic infection might be the initial step for successful management of postoperative BPF. Larger size of pleural cavity, thicker pleural cavitary wall, and size increase of the pleural cavity were frequent findings in patients with complicated BPF in our study. Any clinical factors were not helpful in predicting the development of thoracic infection. CT analysis and follow-up might be more important to predict disease progression. The risk factors for progression to chronic disease were found to be older age (over 70 years), a cavitary wall thickness over 5mm, and an increase in cavity size on follow-up, in our study. The pleural thickness of empyema demonstrated on CT was in agreement with empyema stage in a previous report. Cavitary wall thickness over 5 mm correlated with late stage II and III empyema, requiring surgical decortication (18). In our patients with pleural thickness exceeding 5 mm, 58.3% (7/11) of patients progressed to chronic complicated BPF. Mao et al. (14) suggested the significance of observation of gradual narrowing of cavities in follow-up of cases under conservative management of empyema-complicated BPF. Radiologic improvement of pleural opacity was considered to be an important indicator for managing empyema without surgery (19). Although there have been several studies of the role of CT in management of BPF in prior studies, we suggest that CT follow-up as well as an initial CT evaluation is necessary for successful management (71720). Evaluation of pleural cavity wall thickness and changes in pleural cavity size on follow-up CT may facilitate clinical decision-making between surgical and conservative management. This study had several limitations. First, this study was retrospective, which implies the possibility of selection bias when patients were initially selected by imaging diagnosis. BPF diagnosed by bronchoscopy or surgery only were not included. Determination of complications was also based on imaging diagnosis. However, in recent clinical practice, CT is a more practical method to diagnose postoperative BPF, as bronchoscopy and surgical diagnosis is not appropriate for all patients. Second, the number of patients in each group was too small to generalize the results. In conclusion, we here identified several findings on follow-up CT that can allow prediction of development of chronic BPF. Old age, thicker pleural cavitary wall, and size change of the pleural cavity on follow-up CT scans were factors associated with progression to chronic complicated BPF. Follow-up CT might be helpful for early detection of chronic complicated BPF and for the clinical decision-making about managing postoperative BPF.
  19 in total

1.  Incidence and Management of Post-Lobectomy and Pneumonectomy Bronchopleural Fistula.

Authors:  Leonello Fuso; Francesco Varone; Dania Nachira; Ilaria Leli; Ivano Salimbene; Maria Teresa Congedo; Stefano Margaritora; Pierluigi Granone
Journal:  Lung       Date:  2016-01-11       Impact factor: 2.584

2.  Parietal pleural changes in empyema: appearances at CT.

Authors:  R J Waite; R J Carbonneau; J P Balikian; C B Umali; A T Pezzella; G Nash
Journal:  Radiology       Date:  1990-04       Impact factor: 11.105

3.  Empyema and bronchopleural fistula after pneumonectomy: factors affecting incidence.

Authors:  C Deschamps; A Bernard; F C Nichols; M S Allen; D L Miller; V F Trastek; G D Jenkins; P C Pairolero
Journal:  Ann Thorac Surg       Date:  2001-07       Impact factor: 4.330

4.  Natural history of bronchopleural fistula after pneumonectomy: a review of 96 cases.

Authors:  P H Hollaus; F Lax; B B el-Nashef; H H Hauck; P Lucciarini; N S Pridun
Journal:  Ann Thorac Surg       Date:  1997-05       Impact factor: 4.330

5.  The role of computed tomography bronchography in the management of bronchopleural fistulas.

Authors:  Pralay Sarkar; Nick Patel; Jessie Chusid; Rakesh Shah; Arunabh Talwar
Journal:  J Thorac Imaging       Date:  2010-02       Impact factor: 3.000

6.  Conservative management of empyema-complicated post-lobectomy bronchopleural fistulas: experience of consecutive 13 cases in 9 years.

Authors:  Rui Mao; Peng-Qing Ying; Dong Xie; Chen-Yang Dai; Jun-Yan Zha; Tao Chen; Ge-Ning Jiang; Ke Fei; Chang Chen
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 7.  Diabetes Mellitus and Risk of Bronchopleural Fistula After Pulmonary Resections: A Meta-Analysis.

Authors:  Shuang-Jiang Li; Jun Fan; Jian Zhou; Yu-Tao Ren; Cheng Shen; Guo-Wei Che
Journal:  Ann Thorac Surg       Date:  2016-04-08       Impact factor: 4.330

8.  Conservative management of postoperative bronchopleural fistulas.

Authors:  Mohamed Sadok Boudaya; Hanène Smadhi; Hazem Zribi; Jalel Mohamed; Jamel Ammar; Taher Mestiri; Tarek Kilani
Journal:  J Thorac Cardiovasc Surg       Date:  2013-06-28       Impact factor: 5.209

9.  Peripheral bronchopleural fistula: CT evaluation in 20 patients with pneumonia, empyema, or postoperative air leak.

Authors:  J L Westcott; J P Volpe
Journal:  Radiology       Date:  1995-07       Impact factor: 11.105

10.  Can Peripheral Bronchopleural Fistula Demonstrated on Computed Tomography be Treated Conservatively? A Retrospective Analysis.

Authors:  Maho Tsubakimoto; Sadayuki Murayama; Rin Iraha; Hisashi Kamiya; Nanae Tsuchiya; Tsuneo Yamashiro
Journal:  J Comput Assist Tomogr       Date:  2016 Jan-Feb       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.